Clinical trial
A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as…
NCT00203476 · Tuscaloosa Research & Education Advancement Corporation, Other · Completed
Key facts
| NCT number | NCT00203476 |
|---|---|
| Title | A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction |
| Official title | A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction |
| Lead sponsor | Tuscaloosa Research & Education Advancement Corporation, Other |
| Collaborators | American Society of Health-System Pharmacists Research and Education Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hyperlipidemia, Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Niacin, Colestipol, Ezetimibe |
| Enrollment | 30 |
| Start date | May 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 12, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: